Arkolith/Insider Trading/ARQT/Form 4

Burnett Patrick

See RemarksArcutis Biotherapeutics, Inc. (ARQT) · full profile →Form 4 · filed Dec 17, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$333K
Net Open-Market Flow
-$333K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 15, 2025Sell(S)12K$28.94$333K98K
Dec 15, 2025Option exercise(M)12K$3.64$42K110K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 15, 2025Option exercise(M)12K—$0144K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001741987-25-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML